Abstract
Summary
Functional hypothalamic amenorrhea (FHA) impairs the attainment of peak bone mass and as such can increase the risk of fractures later in life. To document available treatment strategies, we conducted a systematic review of the literature. We report that hormonal therapies have limited effectiveness in increasing bone mass, whereas increased caloric intake resulting in weight gain and/or resumption of menses is an essential strategy for restoring bone mass in women with FHA.
Introduction
Women with functional hypothalamic amenorrhea (FHA) may not achieve peak bone mass (PBM), which increases the risk of stress fractures, and may increase the risk of osteoporotic fractures in later life.
Methods
To identify effective treatment strategies for women with FHA, we conducted a systematic review of the literature. We included randomized controlled trials (RCTs), cross-sectional studies, and case studies that reported on the effects of pharmacological and non-pharmacological interventions on bone mineral density (BMD) or bone turnover in women with FHA.
Results
Most published studies (n = 26) were designed to treat the hormonal abnormities observed in women with FHA (such as low estrogen, leptin, insulin-like growth factor-1, and DHEA); however none of these treatments demonstrated consistent improvements in BMD. Therapies containing an estrogen given for 8–24 months resulted in variable improvements (1.0–19.0%) in BMD, but failed to restore bone mass to that of age-matched controls. Three studies reported on the use of bisphosphonates (3–12 months) in anorexic women, which appear to have limited effectiveness to improve BMD compared to nutritional treatments. Another three investigations showed no improvements in BMD after androgen therapy (DHEA and testosterone) in anorexic women. In contrast, reports (n = 9) describing an increase in caloric intake that results in weight gain and/or the resumption of menses reported a 1.1–16.9% increase in BMD concomitant with an improvement in bone formation and reduction in bone resorption markers.
Conclusions
Our literature review indicates that the most successful, and indeed essential strategy for improving BMD in women with FHA is to increase caloric intake such that body mass is increased and there is a resumption of menses. Further long-term studies to determine the persistence of this effect and to determine the effects of this and other strategies on fracture risk are needed.
Similar content being viewed by others
References
Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG (2002) Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab 87:3162–3168
Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A (1999) Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84:2049–2055
Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, Herzog D, Klibanski A (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133:790–794
De Souza MJ, Williams NI (2004) Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Updat 10:433–448
Loucks AB, Verdun M, Heath EM (1998) Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 84:37–46
Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302
Riggs BL (2000) The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106:1203–1204
Valentino R, Savastano S, Tommaselli AP, D’Amore G, Dorato M, Lombardi G (2001) The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women. J Clin Endocrinol Metab 86:4674–4678
Bass SL, Eser P, Daly R (2005) The effect of exercise and nutrition on the mechanostat. J Musculoskelet Neuronal Interact 5:239–254
Joy EA, Campbell D (2005) Stress fractures in the female athlete. Curr Sports Med Rep 4:323–328
Berga SL, Loucks TL (2005) The diagnosis and treatment of stress-induced anovulation. Minerva Ginecol 57:45–54
Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R (1992) Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7:1467–1474
Laughlin GA, Yen SS (1996) Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab 81:4301–4309
Liu SL, Lebrun CM (2006) Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med 40:11–24
Rickenlund A, Carlstrom K, Ekblom B, Brismar TB, Von Schoultz B, Hirschberg AL (2004) Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab 89:4364–4370
De Cree C, Lewin R, Ostyn M (1988) Suitability of cyproterone acetate in the treatment of osteoporosis associated with athletic amenorrhea. Int J Sports Med 9:187–192
Cumming DC (1996) Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med 156:2193–2195
Warren MP, Miller KK, Olson WH, Grinspoon SK, Friedman AJ (2005) Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 72:206–211
Karlsson MK, Weigall SJ, Duan Y, Seeman E (2000) Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab 85:3177–3182
Gremion G, Rizzoli R, Slosman D, Theintz G, Bonjour JP (2001) Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur. Med Sci Sports Exerc 33:15–21
Castelo-Branco C, Vicente JJ, Pons F, Martinez de Osaba MJ, Casals E, Vanrell JA (2001) Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives. J Reprod Med 46:875–879
Gibson JH, Mitchell A, Reeve J, Harries MG (1999) Treatment of reduced bone mineral density in athletic amenorrhea: a pilot study. Osteoporos Int 10:284–289
Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG, Hamilton L (2003) Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study. Fertil Steril 80:398–404
Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR (2002) The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 15:135–143
Munoz MT, Morande G, Garcia-Centenera JA, Hervas F, Pozo J, Argente J (2002) The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 146:45–50
Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC (1995) The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898–904
Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS (2002) Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87:4935–4941
Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883–2891
Strokosch GR, Friedman AJ, Wu SC, Kamin M (2006) Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 39:819–827
Hergenroeder AC, Smith EO, Shypailo R, Jones LA, Klish WJ, Ellis K (1997) Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 176:1017–1025
Grinspoon SK, Friedman AJ, Miller KK, Lippman J, Olson WH, Warren MP (2003) Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea. J Clin Endocrinol Metab 88:3651–3656
Garnero P, Sornay-Rendu E, Delmas PD (1995) Decreased bone turnover in oral contraceptive users. Bone 16:499–503
Nappi C, Di Spiezio Sardo A, Acunzo G, Bifulco G, Tommaselli GA, Guida M, Di Carlo C (2003) Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 67:355–359
Paoletti AM, Orru M, Lello S, Floris S, Ranuzzi F, Etzi R, Zedda P, Guerriero S, Fratta S, Sorge R, Mallarini G, Melis GB (2004) Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Contraception 70:293–298
Wreje U, Brynhildsen J, Aberg H, Bystrom B, Hammar M, von Schoultz B (2000) Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use. Contraception 61:265–270
Harel Z, Riggs S (1997) Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa. J Adolesc Health 21:179–182
Patel S (1999) Effect of hormone replacement therapy on bone density in a patient with severe osteoporosis caused by anorexia nervosa. Ann Rheum Dis 58:66
Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS (1999) Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 14:136–145
Miller KK, Grieco KA, Klibanski A (2005) Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 90:1428–1433
Grinspoon SK, Baum HB, Peterson S, Klibanski A (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900–906
Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A (1996) Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864–3870
Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987–997
Nakahara T, Nagai N, Tanaka M, Muranaga T, Kojima S, Nozoe S, Naruo T (2006) The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. Int J Eat Disord 39:20–26
Miller KK, Grieco KA, Mulder J, Grinspoon S, Mickley D, Yehezkel R, Herzog DB, Klibanski A (2004) Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89:3903–3906
Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR (2005) Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179–3185
Holtkamp K, Mika C, Grzella I, Heer M, Pak H, Hebebrand J, Herpertz-Dahlmann B (2003) Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm 110:427–435
Loucks AB, Verdun M (1998) Slow restoration of LH pulsatility by refeeding in energetically disrupted women. Am J Physiol 275:R1218–R1226
Heer M, Mika C, Grzella I, Drummer C, Herpertz-Dahlmann B (2002) Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment. Clin Chem 48:754–760
Herpertz S, Albers N, Wagner R, Pelz B, Kopp W, Mann K, Blum WF, Senf W, Hebebrand J (2000) Longitudinal changes of circadian leptin, insulin and cortisol plasma levels and their correlation during refeeding in patients with anorexia nervosa. Eur J Endocrinol 142:373–379
Holtkamp K, Hebebrand J, Mika C, Grzella I, Heer M, Heussen N, Herpertz-Dahlmann B (2003) The effect of therapeutically induced weight gain on plasma leptin levels in patients with anorexia nervosa. J Psychiatr Res 37:165–169
Daniels TL, Cameron JL, Marcus MD, Berga SL (1997) Recovery from functional hypothalamic amenorrhea (FHA) involves resolution of hypothalamic hypothyroidism. In 79th Annual Meeting of The Endocrine Society. Minneapolis, MN
Heer M, Mika C, Grzella I, Heussen N, Herpertz-Dahlmann B (2004) Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects. Am J Clin Nutr 80:774–781
Viapiana O, Gatti D, Dalle Grave R, Todesco T, Rossini M, Braga V, Idolazzi L, Fracassi E, Adami S (2007) Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone 40:1073–1077
Dominguez J, Goodman L, Sen Gupta S, Mayer L, Etu SF, Walsh BT, Wang J, Pierson R, Warren MP (2007) Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 86:92–99
Fredericson M, Kent K (2005) Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc 37:1481–1486
Drinkwater BL, Nilson K, Ott S, Chesnut CH 3rd (1986) Bone mineral density after resumption of menses in amenorrheic athletes. JAMA 256:380–382
Drinkwater BL, Nilson K, Chesnut CH 3rd, Bremner WJ, Shainholtz S, Southworth MB (1984) Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 311:277–281
Zanker CL, Cooke CB, Truscott JG, Oldroyd B, Jacobs HS (2004) Annual changes of bone density over 12 years in an amenorrheic athlete. Med Sci Sports Exerc 36:137–142
Compston JE, McConachie C, Stott C, Hannon RA, Kaptoge S, Debiram I, Love S, Jaffa A (2006) Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 17:77–84
Bolton JG, Patel S, Lacey JH, White S (2005) A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 16:1955–1962
Miller KK, Lee EE, Lawson EA, Misra M, Minihan J, Grinspoon SK, Gleysteen S, Mickley D, Herzog D, Klibanski A (2006) Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91:2931–2937
Satoh Y, Shimizu T, Lee T, Nishizawa K, Iijima M, Yamashiro Y (2003) Resting energy expenditure and plasma leptin levels in adolescent girls with anorexia nervosa. Int J Eat Disord 34:156–161
Van Wymelbeke V, Brondel L, Marcel Brun J, Rigaud D (2004) Factors associated with the increase in resting energy expenditure during refeeding in malnourished anorexia nervosa patients. Am J Clin Nutr 80:1469–1477
Lob S, Pickel J, Bidlingmaier M, Schaaf L, Backmund H, Gerlinghoff M, Stalla GK (2003) Serum leptin monitoring in anorectic patients during refeeding therapy. Exp Clin Endocrinol Diabetes 111:278–282
Haas V, Onur S, Paul T, Nutzinger DO, Bosy-Westphal A, Hauer M, Brabant G, Klein H, Muller MJ (2005) Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr 81:889–896
Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145:669–673
Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N (2006) Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 91:3697–3710
Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K (2003) Patients with eating disorders. A high-risk group for fractures. Orthop Nurs 22:325–331
Lucas AR, Melton LJ 3rd, Crowson CS, O’Fallon WM (1999) Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 74:972–977
Cobb KL, Bachrach LK, Sowers M, Nieves J, Greendale GA, Kent KK, Brown BW Jr, Pettit K, Harper DM, Kelsey JL (2007) The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc 39:1464–1473
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vescovi, J.D., Jamal, S.A. & De Souza, M.J. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int 19, 465–478 (2008). https://doi.org/10.1007/s00198-007-0518-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-007-0518-6